Masatoshi Ishigami
Papers
1
Total Citations
3
H-Index
1
About
Masatoshi Ishigami is a leading interventional radiologist whose work centers on advancing locoregional therapies for hepatocellular carcinoma (HCC). His primary research focuses on optimizing transarterial chemoembolization (TACE) through innovative emulsification technologies. Ishigami's major contribution lies in demonstrating the clinical effectiveness of a porous glass membrane-pumping emulsification device (GMD), which produces a high-percentage water-in-oil emulsion with remarkably homogeneous and stable droplets. This breakthrough directly addresses a longstanding challenge in interventional oncology—improving the uniformity and durability of drug delivery to liver tumors. His most cited paper, published in 2022, provides compelling evidence that GMD-enhanced TACE yields superior locoregional tumor control for solitary HCC compared to conventional methods. While his citation count is still growing, reflecting the recent nature of this work, the technical novelty and translational significance of his findings have already established him as an innovator in hepatic interventional oncology. Ishigami's research bridges biomedical engineering and clinical practice, offering a tangible path toward more predictable and effective chemoembolization outcomes.
Research Focus
Key Achievements
Top Papers
- 1